Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Total Non-Current Liabilities (2016 - 2025)

AC Immune (ACIU) has disclosed Total Non-Current Liabilities for 9 consecutive years, with $20.3 million as the latest value for Q4 2024.

  • On a quarterly basis, Total Non-Current Liabilities rose 109.76% to $20.3 million in Q4 2024 year-over-year; TTM through Dec 2024 was $20.3 million, a 109.76% increase, with the full-year FY2024 number at $20.3 million, up 112.38% from a year prior.
  • Total Non-Current Liabilities was $20.3 million for Q4 2024 at AC Immune, up from $9.7 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $20.3 million in Q4 2024 to a low of $5.7 million in Q4 2022.
  • A 5-year average of $11.2 million and a median of $10.2 million in 2020 define the central range for Total Non-Current Liabilities.
  • Peak YoY movement for Total Non-Current Liabilities: crashed 44.57% in 2022, then soared 109.76% in 2024.
  • AC Immune's Total Non-Current Liabilities stood at $10.2 million in 2020, then increased by 0.1% to $10.2 million in 2021, then tumbled by 44.57% to $5.7 million in 2022, then skyrocketed by 70.78% to $9.7 million in 2023, then skyrocketed by 109.76% to $20.3 million in 2024.
  • Per Business Quant, the three most recent readings for ACIU's Total Non-Current Liabilities are $20.3 million (Q4 2024), $9.7 million (Q4 2023), and $5.7 million (Q4 2022).